Conversely to the archetypal role of cystatin M/E as a tumor suppressor in breast cancer, the authors suggested that cystatin M/E may be involved in the pathophysiology of TNBC, possibly acting as a tumor-promoting molecule [115]. Here, CST6 is linked to breast carcinoma.